淋巴细胞表达血静因子:儿童急性淋巴细胞白血病中高凝血的机制
Ghada A Aborkhees1, Kevin Dietrich1, Amy J Barr1
1Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
Thrombosis and haemostasis
|October 14, 2025
概括
儿科急性淋巴细胞白血病 (ALL) 淋巴细胞通过表达凝血因子和损害纤维素分解来促进高凝血能力. 这在ALL治疗期间有助于静脉血栓塞栓症 (VTE) 风险.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 静脉血栓栓塞 (VTE) 是儿科急性淋巴细胞白血病 (ALL) 的重要并发症,特别是在诱导治疗期间.
- 白血病淋巴细胞在促进这种高凝血状态中的作用尚未完全理解.
研究的目的:
- 为了调查白血病淋巴细胞是否表达出导致高凝血能力的静血因素.
- 评估溶解淋巴细胞对血栓素和纤维素生成的功能影响.
主要方法:
- 在小儿ALL细胞系和正常淋巴细胞中检查了28个静血因子的mRNA和蛋白质表达,使用RT-PCR和免疫阻塞.
- 在血小板贫乏等离子体中使用细胞溶解物进行了氨酸和纤维素生成试验.
主要成果:
- 白血病淋巴细胞构成性地表达促凝剂,抗凝剂和纤维解质/抗纤维解质因子.
- 溶解的淋巴细胞,但不是完整的细胞,增强的血栓和纤维素生成.
- 白血病溶解体显示纤维解质受损,导致血块溶解时间延长.
结论:
- 白血病淋巴细胞积极促进儿科ALL的高凝血状态.
- 这种贡献是通过增加的前凝性活性和受损的纤维素分解发生的.
- 这些发现为儿科ALL的VTE机制提供了新的见解,强调了淋巴细胞在静血失衡中的作用.
相关概念视频
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Hematopoiesis
8.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.7K
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Production of Formed Elements
3.6K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
3.6K


